Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

SRR655218

GTEX

0190c5ec-06dd-55dd-911f-3b2b7ae84798

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.425
  • SPERMATOGENESIS+0.231
  • HEDGEHOG_SIGNALING+0.188
  • MTORC1_SIGNALING+0.162
  • UV_RESPONSE_DN+0.135
  • OXIDATIVE_PHOSPHORYLATION+0.094
  • HEME_METABOLISM+0.092
  • ANDROGEN_RESPONSE+0.083
  • PEROXISOME+0.060
  • ADIPOGENESIS+0.056

Top 10 suppressed

  • TNFA_SIGNALING_VIA_NFKB-0.412
  • ANGIOGENESIS-0.394
  • ALLOGRAFT_REJECTION-0.374
  • IL6_JAK_STAT3_SIGNALING-0.373
  • COAGULATION-0.347
  • INFLAMMATORY_RESPONSE-0.337
  • INTERFERON_ALPHA_RESPONSE-0.329
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.320
  • INTERFERON_GAMMA_RESPONSE-0.304
  • TGF_BETA_SIGNALING-0.298

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR661973
brain-umap@2
GTEX0.914
2SRR658129
brain-umap@2
GTEX0.896
3SRR655649
brain-umap@2
GTEX0.891
4SRR657754
brain-umap@2
GTEX0.891
5SRR659484
brain-umap@2
GTEX0.890
6SRR661445
brain-umap@2
GTEX0.885
7SRR35579848
breast-umap@18
B0.876
8SRR2167030
brain-umap@2
GTEX0.870
9SRR820623
brain-umap@2
GTEX0.865
10MBCProject_0343_T1_RNA
breast-umap@18
B0.863

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 12 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.425Remibrutinib— uncovered
SPERMATOGENESIS0.231Inavolisib— uncovered
HEDGEHOG_SIGNALING0.188Inavolisib— uncovered
MTORC1_SIGNALING0.162Inavolisib— uncovered
UV_RESPONSE_DN0.135Inavolisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.094Remibrutinib— uncovered
HEME_METABOLISM0.092Temsirolimus— uncovered
ANDROGEN_RESPONSE0.083Inavolisib— uncovered
PEROXISOME0.060Idelalisib— uncovered
ADIPOGENESIS0.056Inavolisib— uncovered
FATTY_ACID_METABOLISM0.056Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.009Idelalisib— uncovered